TNFSF10 and colorectal carcinoma: The biological effects of TRAIL in CRC models, its enhancement of chemosensitivity with standard chemotherapeutic agents and the effect of endogenous TRAIL receptor levels on survival make TRAIL an extremely attractive therapeutic target.